Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.
Consuegra-Fernández M, Julià M, Martínez-Florensa M, Aranda F, Català C, Armiger-Borràs N, Arias MT, Santiago F, Guilabert A, Esteve A, Muñoz C, Ferrándiz C, Carrascosa JM, Pedrosa E, Romaní J, Alsina M, Mascaró-Galy JM, Lozano F. Consuegra-Fernández M, et al. Cell Mol Immunol. 2018 Oct;15(10):898-906. doi: 10.1038/cmi.2017.119. Epub 2017 Dec 11. Cell Mol Immunol. 2018. PMID: 29225340 Free PMC article.
Conserved Bacterial-Binding Peptides of the Scavenger-Like Human Lymphocyte Receptor CD6 Protect From Mouse Experimental Sepsis.
Martínez-Florensa M, Català C, Velasco-de Andrés M, Cañadas O, Fraile-Ágreda V, Casadó-Llombart S, Armiger-Borràs N, Consuegra-Fernández M, Casals C, Lozano F. Martínez-Florensa M, et al. Among authors: consuegra fernandez m. Front Immunol. 2018 Apr 12;9:627. doi: 10.3389/fimmu.2018.00627. eCollection 2018. Front Immunol. 2018. PMID: 29706953 Free PMC article.
Genetically defined variants of toll-like receptors 3, 7 and 9 as phenotype and risk modifier factors for psoriasis.
Julià M, Consuegra-Fernández M, Guilabert A, Muñoz C, Esteve A, Armiger-Borràs N, Santiago F, Arias MT, Romaní J, Ferrándiz C, Carrascosa JM, Pedrosa E, Alsina-Gibert M, Lozano F, Mascaró-Galy JM. Julià M, et al. Among authors: consuegra fernandez m. J Dermatol Sci. 2018 Mar;89(3):301-304. doi: 10.1016/j.jdermsci.2017.12.004. Epub 2017 Dec 19. J Dermatol Sci. 2018. PMID: 29290528 No abstract available.
Corrigendum to "Genetically defined variants of toll-like receptors 3, 7 and 9 as phenotype and risk modifier factors for psoriasis" [89 (March (3)) (2018) 301-304].
Julià M, Consuegra-Fernández M, Guilabert A, Muñoz C, Esteve A, Armiger-Borràs N, Santiago F, Arias MT, Romaní J, Ferrándiz C, Carrascosa JM, Pedrosa E, Alsina-Gibert M, Lozano F, Mascaró-Galy JM. Julià M, et al. Among authors: consuegra fernandez m. J Dermatol Sci. 2018 Sep;91(3):342. doi: 10.1016/j.jdermsci.2018.03.013. Epub 2018 Apr 1. J Dermatol Sci. 2018. PMID: 29615327 No abstract available.
CD5 as a Target for Immune-Based Therapies.
Consuegra-Fernández M, Aranda F, Simões I, Orta M, Sarukhan A, Lozano F. Consuegra-Fernández M, et al. Crit Rev Immunol. 2015;35(2):85-115. doi: 10.1615/critrevimmunol.2015013532. Crit Rev Immunol. 2015. PMID: 26351145 Review.
CD6 modulates thymocyte selection and peripheral T cell homeostasis.
Orta-Mascaró M, Consuegra-Fernández M, Carreras E, Roncagalli R, Carreras-Sureda A, Alvarez P, Girard L, Simões I, Martínez-Florensa M, Aranda F, Merino R, Martínez VG, Vicente R, Merino J, Sarukhan A, Malissen M, Malissen B, Lozano F. Orta-Mascaró M, et al. J Exp Med. 2016 Jul 25;213(8):1387-97. doi: 10.1084/jem.20151785. Epub 2016 Jul 4. J Exp Med. 2016. PMID: 27377588 Free PMC article.
Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis.
Martínez-Florensa M, Consuegra-Fernández M, Aranda F, Armiger-Borràs N, Di Scala M, Carrasco E, Pachón J, Vila J, González-Aseguinolaza G, Lozano F. Martínez-Florensa M, et al. Antimicrob Agents Chemother. 2016 Dec 27;61(1):e01391-16. doi: 10.1128/AAC.01391-16. Print 2017 Jan. Antimicrob Agents Chemother. 2016. PMID: 27895015 Free PMC article.
Gut microbiota metabolites for sweetening type I diabetes.
Aljutaily T, Consuegra-Fernández M, Aranda F, Lozano F, Huarte E. Aljutaily T, et al. Cell Mol Immunol. 2018 Feb;15(2):92-95. doi: 10.1038/cmi.2017.65. Epub 2017 Jul 31. Cell Mol Immunol. 2018. PMID: 28757611 Free PMC article. No abstract available.
21 results